Dr. Corrado Tamburino, principal investigator for the ATLANTA study, stated, "I perform many angioplasties each day, and I am impressed by the performance of this stent in a very complex patient population. No thrombosis. Low binary restenosis. No MIs." The CATANIA(TM) Stent System with NanoThin Polyzene(R)-F has completed CE marking and is available for sale anywhere the CE mark is accepted.
CeloNova BioSciences Introduces New Coronary Stent
Published on : Mon, 11 Feb 2008
Print as PDF